Pracownia Badan Klinicznych Salus

At Pracownia Badan Klinicznych Salus researchers are evaluating innovative therapies for ulcerative colitis, aiming to improve remission rates and patient quality of life.

• Exploration of novel biologic agents for moderate‑to‑severe disease
• Integration of patient‑reported outcomes in treatment assessment
• Development of precision‑medicine approaches based on disease biomarkers

The site currently supports two active studies with a team of four investigators, contributing to advancing care for digestive health in Europe.

Clinical investigations at the centre focus on Sjögren’s disease, testing a targeted biologic to reduce systemic activity and enhance daily functioning.

• Assessment of immune‑modulating therapies for autoimmune conditions
• Safety and tolerability profiling of new immunotherapeutics
• Long‑term monitoring of disease activity scores

With a dedicated group of investigators, the facility is contributing valuable data to the global effort of improving treatments for immune‑mediated disorders.

The research program includes studies on ocular surface disorders, such as dry eye syndrome, which often accompany systemic autoimmune diseases.

• Evaluation of anti‑inflammatory eye drops for symptom relief
• Investigation of novel lubricating formulations to protect corneal health
• Quality‑of‑life assessments for patients with chronic eye irritation

Located in Wroclaw, Poland, the site leverages its multidisciplinary expertise to address both systemic and ocular aspects of disease.